{"id":329,"date":"2012-05-13T01:22:01","date_gmt":"2012-05-13T01:22:01","guid":{"rendered":"http:\/\/stg-blogs.bmj.com\/jmg\/?p=329"},"modified":"2012-05-13T01:22:01","modified_gmt":"2012-05-13T01:22:01","slug":"prostate-cancer-risk-assessment-model-a-scoring-model-based-on-the-swedish-family-cancer-database","status":"publish","type":"post","link":"https:\/\/stg-blogs.bmj.com\/jmg\/2012\/05\/13\/prostate-cancer-risk-assessment-model-a-scoring-model-based-on-the-swedish-family-cancer-database\/","title":{"rendered":"Prostate cancer risk assessment model: a scoring model based on the Swedish Family-Cancer Database"},"content":{"rendered":"<p>Prostate cancer is the most common cancer in men and family history of cancer and age are the strongest contributing factors. We followed about 600,000 men from the Swedish Family-Cancer Database (world\u2019s largest of its kind) for 10 years to design the Prostate Cancer Risk Assessment Model (PCRAM) for the first time, which enables clinicians to assess a man\u2019s risk of prostate cancer based on his personal and family history of prostate, oesophagus and breast cancers. PCRAM, which was successfully tested in another large sample, also contains a chart of equivalent ages by risk score that assists health care providers to estimate when to begin prostate cancer screening individually. (By Mahdi Fallah, MD, PhD, <a href=\"http:\/\/jmg.bmj.com\/content\/49\/5\/345\">http:\/\/jmg.bmj.com\/content\/49\/5\/345<\/a> )<!--TrendMD v2.4.8--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Prostate cancer is the most common cancer in men and family history of cancer and age are the strongest contributing factors. We followed about 600,000 men from the Swedish Family-Cancer Database (world\u2019s largest of its kind) for 10 years to design the Prostate Cancer Risk Assessment Model (PCRAM) for the first time, which enables clinicians [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/stg-blogs.bmj.com\/jmg\/2012\/05\/13\/prostate-cancer-risk-assessment-model-a-scoring-model-based-on-the-swedish-family-cancer-database\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-329","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/stg-blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/329","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stg-blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stg-blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=329"}],"version-history":[{"count":0,"href":"https:\/\/stg-blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/329\/revisions"}],"wp:attachment":[{"href":"https:\/\/stg-blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=329"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=329"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=329"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}